PAIRED-LIKE HOMEODOMAIN PROTEINS, PHOX2A AND PHOX2B, ARE RESPONSIBLE FOR NORADRENERGIC CELL-SPECIFIC TRANSCRIPTION OF THE DOPAMINE-BETA-HYDROXYLASE GENE
Cy. Yang et al., PAIRED-LIKE HOMEODOMAIN PROTEINS, PHOX2A AND PHOX2B, ARE RESPONSIBLE FOR NORADRENERGIC CELL-SPECIFIC TRANSCRIPTION OF THE DOPAMINE-BETA-HYDROXYLASE GENE, Journal of neurochemistry, 71(5), 1998, pp. 1813-1826
Recently, a murine paired-like homeobox gene, Phox2a, has been identif
ied whose product is critical for the development of several major nor
adrenergic neuron populations, including the locus coeruleus. In norad
renergic neurons, dopamine P-hydroxylase (DBH) is a hallmark protein a
nd catalyzes the conversion of dopamine to noradrenaline, Our previous
studies have shown that a composite promoter (domain IV), residing at
-185 to -150 bp upstream of the transcription start site, is critical
for DBH transcription and is comprised of multiple cis-acting element
s, including a cyclic AMP response element, a YY1 binding site, and tw
o core motifs of the homeodomain (HD)-binding site. Here, we show that
the HD-binding site residing within domain IV is a noradrenergic-spec
ific cis-acting element. In contrast, the cyclic AMP response element
is active in all cell lines tested. We provide evidence that Phox2a is
expressed only in DBH-positive cell lines and interacts with the HD-b
inding site. Forced expression of Phox2a robustly activates DBH promot
er activity in DBH-negative cell lines (>10-fold), but increased it on
ly marginally (<50%) in DBH-positive cell lines. Furthermore, another
protein factor with an identical HD, Phox2b, also activates DBH transc
ription with an efficiency comparable to that of Phox2a, In contrast,
neither Phox2a nor Phox2b was able to transactivate tyrosine hydroxyla
se transcription, indicating that these transcription factors differen
tially activate catecholamine-synthesizing gene transcription. Togethe
r with the Phox2a knockout experiment, the studies described here make
Phox2a and Phox2b the first strong candidate transcription factors fo
r determining a neurotransmitter phenotype in vertebrates.